Laboratoire Français du Fractionnement et des Biotechnologies
发明人:
Harry A. Meade,Li-How Chen
申请号：
US16192214
公开号：
US20190309057A1
申请日:
2018.11.15
申请国别(地区):
US
年份:
2019
代理人:
摘要：
In one aspect, the disclosure relates to highly galactosylated anti-TNF-alpha antibodies and compositions thereof. In one aspect, the disclosure relates to populations of anti-TNF-alpha antibodies with a high level of galactosylation, and compositions thereof. In one aspect, the disclosure relates to methods of production and use of highly galactosylated anti-TNF-alpha antibodies and populations of anti-TNF-alpha antibodies with a high level of galactosylation. In some embodiments, the anti-TNF-alpha antibody is adalimumab.
